Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA Based Therapeutics market report explains the definition, types, applications, major countries, and major players of the RNA Based Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Benitec Biopharma Limited (Australia)
Tekmira Pharmaceuticals Corp (Canada)
Dicerna Pharmaceuticals (USA)
ISIS pharmaceuticals (USA)
Quark Pharmaceuticals (USA)
Alnylam Pharmaceuticals (USA)
Genzyme Corporation (USA)
Cenix BioScience GmbH (Germany)
Silence Therapeutics PLC (UK)
By Type:
qRT-PCR
RNA Interference (RNAi) Technologies
RNA Antisense
Inhibition
Microarrays
Labeling
Purification
By End-User:
Cardiovascular
Kidney Diseases
Oncology
Infectious Diseases
Metabolic Disorders
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global RNA Based Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 RNA Based Therapeutics Outlook to 2028- Original Forecasts
-
2.2 RNA Based Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term RNA Based Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global RNA Based Therapeutics Market- Recent Developments
-
6.1 RNA Based Therapeutics Market News and Developments
-
6.2 RNA Based Therapeutics Market Deals Landscape
7 RNA Based Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 RNA Based Therapeutics Key Raw Materials
-
7.2 RNA Based Therapeutics Price Trend of Key Raw Materials
-
7.3 RNA Based Therapeutics Key Suppliers of Raw Materials
-
7.4 RNA Based Therapeutics Market Concentration Rate of Raw Materials
-
7.5 RNA Based Therapeutics Cost Structure Analysis
-
7.5.1 RNA Based Therapeutics Raw Materials Analysis
-
7.5.2 RNA Based Therapeutics Labor Cost Analysis
-
7.5.3 RNA Based Therapeutics Manufacturing Expenses Analysis
8 Global RNA Based Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global RNA Based Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global RNA Based Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global RNA Based Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global RNA Based Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global qRT-PCR Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RNA Interference (RNAi) Technologies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global RNA Antisense Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Inhibition Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Microarrays Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Labeling Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Purification Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA Based Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
10 Region and Country-wise RNA Based Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global RNA Based Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States RNA Based Therapeutics Consumption (2017-2022)
-
10.2.2 Canada RNA Based Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico RNA Based Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany RNA Based Therapeutics Consumption (2017-2022)
-
10.3.2 UK RNA Based Therapeutics Consumption (2017-2022)
-
10.3.3 Spain RNA Based Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium RNA Based Therapeutics Consumption (2017-2022)
-
10.3.5 France RNA Based Therapeutics Consumption (2017-2022)
-
10.3.6 Italy RNA Based Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark RNA Based Therapeutics Consumption (2017-2022)
-
10.3.8 Finland RNA Based Therapeutics Consumption (2017-2022)
-
10.3.9 Norway RNA Based Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden RNA Based Therapeutics Consumption (2017-2022)
-
10.3.11 Poland RNA Based Therapeutics Consumption (2017-2022)
-
10.3.12 Russia RNA Based Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey RNA Based Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China RNA Based Therapeutics Consumption (2017-2022)
-
10.4.2 Japan RNA Based Therapeutics Consumption (2017-2022)
-
10.4.3 India RNA Based Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea RNA Based Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan RNA Based Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh RNA Based Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia RNA Based Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand RNA Based Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore RNA Based Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia RNA Based Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines RNA Based Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam RNA Based Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil RNA Based Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia RNA Based Therapeutics Consumption (2017-2022)
-
10.5.3 Chile RNA Based Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina RNA Based Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela RNA Based Therapeutics Consumption (2017-2022)
-
10.5.6 Peru RNA Based Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico RNA Based Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador RNA Based Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain RNA Based Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait RNA Based Therapeutics Consumption (2017-2022)
-
10.6.3 Oman RNA Based Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar RNA Based Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia RNA Based Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates RNA Based Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria RNA Based Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa RNA Based Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt RNA Based Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria RNA Based Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia RNA Based Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand RNA Based Therapeutics Consumption (2017-2022)
11 Global RNA Based Therapeutics Competitive Analysis
-
11.1 Benitec Biopharma Limited (Australia)
-
11.1.1 Benitec Biopharma Limited (Australia) Company Details
-
11.1.2 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Main Business and Markets Served
-
11.1.4 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Tekmira Pharmaceuticals Corp (Canada)
-
11.2.1 Tekmira Pharmaceuticals Corp (Canada) Company Details
-
11.2.2 Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Main Business and Markets Served
-
11.2.4 Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Dicerna Pharmaceuticals (USA)
-
11.3.1 Dicerna Pharmaceuticals (USA) Company Details
-
11.3.2 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
11.3.4 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 ISIS pharmaceuticals (USA)
-
11.4.1 ISIS pharmaceuticals (USA) Company Details
-
11.4.2 ISIS pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 ISIS pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
11.4.4 ISIS pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Quark Pharmaceuticals (USA)
-
11.5.1 Quark Pharmaceuticals (USA) Company Details
-
11.5.2 Quark Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Quark Pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
11.5.4 Quark Pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Alnylam Pharmaceuticals (USA)
-
11.6.1 Alnylam Pharmaceuticals (USA) Company Details
-
11.6.2 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
11.6.4 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Genzyme Corporation (USA)
-
11.7.1 Genzyme Corporation (USA) Company Details
-
11.7.2 Genzyme Corporation (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Genzyme Corporation (USA) RNA Based Therapeutics Main Business and Markets Served
-
11.7.4 Genzyme Corporation (USA) RNA Based Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Cenix BioScience GmbH (Germany)
-
11.8.1 Cenix BioScience GmbH (Germany) Company Details
-
11.8.2 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Main Business and Markets Served
-
11.8.4 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Silence Therapeutics PLC (UK)
-
11.9.1 Silence Therapeutics PLC (UK) Company Details
-
11.9.2 Silence Therapeutics PLC (UK) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Silence Therapeutics PLC (UK) RNA Based Therapeutics Main Business and Markets Served
-
11.9.4 Silence Therapeutics PLC (UK) RNA Based Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global RNA Based Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global RNA Based Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global qRT-PCR Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global RNA Interference (RNAi) Technologies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global RNA Antisense Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Inhibition Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Labeling Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Purification Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global RNA Based Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise RNA Based Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia RNA Based Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand RNA Based Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of RNA Based Therapeutics
-
Figure of RNA Based Therapeutics Picture
-
Table Global RNA Based Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global RNA Based Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global qRT-PCR Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Interference (RNAi) Technologies Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Antisense Consumption and Growth Rate (2017-2022)
-
Figure Global Inhibition Consumption and Growth Rate (2017-2022)
-
Figure Global Microarrays Consumption and Growth Rate (2017-2022)
-
Figure Global Labeling Consumption and Growth Rate (2017-2022)
-
Figure Global Purification Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Based Therapeutics Consumption by Country (2017-2022)
-
Table North America RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure United States RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure Germany RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure China RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania RNA Based Therapeutics Consumption by Country (2017-2022)
-
Figure Australia RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand RNA Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Benitec Biopharma Limited (Australia) Company Details
-
Table Benitec Biopharma Limited (Australia) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benitec Biopharma Limited (Australia) RNA Based Therapeutics Main Business and Markets Served
-
Table Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product Portfolio
-
Table Tekmira Pharmaceuticals Corp (Canada) Company Details
-
Table Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Main Business and Markets Served
-
Table Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Product Portfolio
-
Table Dicerna Pharmaceuticals (USA) Company Details
-
Table Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
Table Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
Table ISIS pharmaceuticals (USA) Company Details
-
Table ISIS pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ISIS pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
Table ISIS pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
Table Quark Pharmaceuticals (USA) Company Details
-
Table Quark Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark Pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
Table Quark Pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
Table Alnylam Pharmaceuticals (USA) Company Details
-
Table Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Main Business and Markets Served
-
Table Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product Portfolio
-
Table Genzyme Corporation (USA) Company Details
-
Table Genzyme Corporation (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation (USA) RNA Based Therapeutics Main Business and Markets Served
-
Table Genzyme Corporation (USA) RNA Based Therapeutics Product Portfolio
-
Table Cenix BioScience GmbH (Germany) Company Details
-
Table Cenix BioScience GmbH (Germany) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cenix BioScience GmbH (Germany) RNA Based Therapeutics Main Business and Markets Served
-
Table Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product Portfolio
-
Table Silence Therapeutics PLC (UK) Company Details
-
Table Silence Therapeutics PLC (UK) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics PLC (UK) RNA Based Therapeutics Main Business and Markets Served
-
Table Silence Therapeutics PLC (UK) RNA Based Therapeutics Product Portfolio
-
Figure Global qRT-PCR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA Interference (RNAi) Technologies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA Antisense Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhibition Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microarrays Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Labeling Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Purification Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania RNA Based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
